Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Public Library of Science full text link Public Library of Science Free PMC article
Full text links

Actions

.2015 Oct 6;9(10):e0004141.
doi: 10.1371/journal.pntd.0004141. eCollection 2015.

New Insights into the Geographic Distribution of Mycobacterium leprae SNP Genotypes Determined for Isolates from Leprosy Cases Diagnosed in Metropolitan France and French Territories

Affiliations

New Insights into the Geographic Distribution of Mycobacterium leprae SNP Genotypes Determined for Isolates from Leprosy Cases Diagnosed in Metropolitan France and French Territories

Florence Reibel et al. PLoS Negl Trop Dis..

Abstract

Background: Between 20 and 30 bacteriologically confirmed cases of leprosy are diagnosed each year at the French National Reference Center for mycobacteria. Patients are mainly immigrants from various endemic countries or living in French overseas territories. We aimed at expanding data regarding the geographical distribution of the SNP genotypes of the M. leprae isolates from these patients.

Methodology/principal findings: Skin biopsies were obtained from 71 leprosy patients diagnosed between January 2009 and December 2013. Data regarding age, sex and place of birth and residence were also collected. Diagnosis of leprosy was confirmed by microscopic detection of acid-fast bacilli and/or amplification by PCR of the M. leprae-specific RLEP region. Single nucleotide polymorphisms (SNP), present in the M. leprae genome at positions 14 676, 1 642 875 and 2 935 685, were determined with an efficiency of 94% (67/71). Almost all patients were from countries other than France where leprosy is still prevalent (n = 31) or from French overseas territories (n = 36) where leprosy is not totally eradicated, while only a minority (n = 4) was born in metropolitan France but have lived in other countries. SNP type 1 was predominant (n = 33), followed by type 3 (n = 17), type 4 (n = 11) and type 2 (n = 6). SNP types were concordant with those previously reported as prevalent in the patients' countries of birth. SNP types found in patients born in countries other than France (Comoros, Haiti, Benin, Congo, Sri Lanka) and French overseas territories (French Polynesia, Mayotte and La Réunion) not covered by previous work correlated well with geographical location and history of human settlements.

Conclusions/significance: The phylogenic analysis of M. leprae strains isolated in France strongly suggests that French leprosy cases are caused by SNP types that are (a) concordant with the geographic origin or residence of the patients (non-French countries, French overseas territories, metropolitan France) or (b) more likely random in regions where diverse migration flows occurred.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Leprosy cases diagnosed in France (2009–2013): correlation between SNP genotype and geographical origin of the patient.
(Total = 66 cases, for 1 one of the 67 cases included in our study the country where leprosy was acquired in unknown). *indicates countries for which no previous SNP data were available. Underlined countries indicate the French overseas territories. For Congo: 1 patient was born in DRC, 1 patient was born in RC, 1 patient was born in France but has lived in DRC and 1 patient was born in France but has lived in Congo without further information.
See this image and copyright information in PMC

References

    1. WHO. World health Assembly, Elimination of leprosy: resolution of the 44th World Health Assembly Geneva: World Health Organization; 1991, Resolution No. WHA 44.
    1. WHO. Global leprosy update, 2013; reducing disease burden. Wkly Epidemiol Rec, 2014. 89(36): p. 389–400. - PubMed
    1. WHO Expert Committee on Leprosy. World Health Organ Tech Rep Ser, 2012(968): p. 1–61. - PubMed
    1. Cambau E, Chauffour-Nevejans A, Tejmar-Kolar L, Matsuoka M, and Jarlier V. Detection of antibiotic resistance in leprosy using GenoType LepraeDR, a novel ready-to-use molecular test. PLoS Negl Trop Dis, 2012. 6(7): p. e1739 10.1371/journal.pntd.0001739 - DOI - PMC - PubMed
    1. Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux (CNR-MyRMA). Rapport d’activité pour l’année 2013.http://cnrmyctb.free.fr/IMG/pdf/Rapport_CNR_2013_web.pdf, 2014.

Publication types

MeSH terms

LinkOut - more resources

Full text links
Public Library of Science full text link Public Library of Science Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2026 Movatter.jp